Evidence map›Paper›PMID 32652585›Full record

Trial reportBritish journal of haematology2020

Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.

Paul J Hengeveld, Aaram O Khader, Linda H A de Bruin, Inge G P Geelen, Eske A van Baalen, Eva Jansen, Nathalie I Bouwer, Ömer Balak, Jurgen A Riedl, Anton W Langerak and 2 more

Abstract readClinical TrialComparative StudyLetter
In one paragraph

Trial report in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. mFrontiers in immunology · 2021
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paul J HengeveldDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID 0000-0002-0070-138X
Aaram O KhaderDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Linda H A de BruinResult Laboratory, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Inge G P GeelenDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID 0000-0001-9470-476X
Eske A van BaalenDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Eva JansenDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Nathalie I BouwerDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID 0000-0002-2048-2233
Ömer BalakDepartment of Pulmonology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Jurgen A RiedlResult Laboratory, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Anton W LangerakLaboratory Medical Immunology, Erasmus MC, Rotterdam, the Netherlands.ORCID 0000-0002-2078-3220
Peter E WesterweelDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID 0000-0002-0746-7039
Mark-David LevinDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID 0000-0003-2139-3547

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Hospital MortalityPandemicsSARS-CoV-2AdultFemaleHumansLymphocyte CountLymphocyte SubsetsMaleMiddle AgedProspective StudiesCOVID-19immunophenotypinglymphocyteslymphopeniasubsets

Identifiers

PMID32652585
PMCPMC7404648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.